Skip to Content


In the Matter of Pure H20 Bio-Technologies, Inc.; Order of Suspension of Trading

Document Details

Information about this document as published in the Federal Register.

Enhanced Content

Relevant information about this document from provides additional context. This information is not part of the official Federal Register document.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble Start Printed Page 70617 November 22, 2013.

It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of Pure H20 Bio-Technologies, Inc. because questions have arisen as to its operating status, if any.

The Commission is of the opinion that the public interest and the protection of the investors require a suspension of trading in the securities of the above-listed company.

Therefore, it is ordered, pursuant to Section 12(k) of the Securities Exchange Act of 1934, that trading in the securities of the above-listed company is suspended for the period from 9:30 a.m. EST on November 22, 2013, through 11:59 p.m. EST on December 6, 2013.

Start Signature

By the Commission.

Jill M. Peterson,

Assistant Secretary,

End Signature End Preamble

[FR Doc. 2013-28447 Filed 11-22-13; 11:15 am]